The biomedical accelerator mass spectrometry (AMS) initiative at PRIME Lab including the status of equipment and sample preparation is described. Several biomedical projects are underway involving one or more of the nuclides: 14C, 26Al and 41Ca. Routine production of CaF2 and graphite is taking place. Finally, the future direction and plans for improvement of the biomedical program at PRIME Lab are discussed.
Journal
Title
Published at:Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Volume 172, Issues 1-4, October 2000, Pages 899-903